📈 Markets & Finance
Live
Is Grail (GRAL) Stock a Buy, Sell, or Hold at Under $70?
Written by Leo Sun for The Motley Fool -> Grail’s stock crashed after Galleri’s NHS England trial missed its primary endpoint. But it’s still generating plenty of revenue without an FDA approval. G
Nasdaq News — 1 August 2026
Text:
23
0
0
Grail’s stock crashed after Galleri’s NHS England trial missed its primary endpoint.
But it’s still generating plenty of revenue without an FDA appro
Read Full Story at Nasdaq News → Sources
📈 Markets & Finance
Trump finalizes new tariffs on dozens of countries
📈 Markets & Finance
Little Movement Seen For Thai Stock Market
📈 Markets & Finance
Where Will Solana Be in 3 Years?
📈 Markets & Finance
Ethereum Foundation adds SEAL 911 co-founder to board as privacy focus grows
📈 Markets & Finance
Analysts predict Chinese stock market rebound following U.S. election results
📈 Markets & Finance
American Airlines Cut Its Full-Year Guidance. The Stock Rose 6.8% the Next Day.
